Home › Cancro metastatico › Texas › Irving
Studi clinici su Cancro metastatico a Irving, TX
11 studi su Cancro metastatico cercano partecipanti presso sedi a Irving e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
In reclutamentoFase 1/2
- Avenzo Therapeutics Recruiting Site, Irving
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology Dallas, Irving
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- NEXT Dallas, Irving
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
In reclutamentoFase 1
- Next Oncology - Dallas, Irving
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
In reclutamentoFase 1/2
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
In reclutamentoFase 1/2
- Crinetics Study Site, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
In reclutamentoFase 1
- NEXT Oncology Dallas, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
In reclutamentoFase 1
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
In reclutamentoFase 1/2
- NEXT Dallas, Irving
Studi su Cancro metastatico in altre città
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Altri studi a Irving
- Cancro del polmone non a piccole cellule22 studi
- Cancro (tutti i tipi)15 studi
- Cancro colorettale13 studi
- Cancro al seno7 studi
- Cancro dello stomaco7 studi
- Cancro pancreatico7 studi
- Carcinoma a cellule squamose della testa e del collo6 studi
- Carcinoma polmonare a piccole cellule6 studi
- Cancro ai polmoni6 studi
- Cancro ovarico5 studi
- Cancro dell'endometrio4 studi
- Cancro al seno triplo negativo4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.